We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Current and future trends in immunization against meningitis.
- Authors
Jones, D. M.
- Abstract
The progress in vaccines for Haemophilus influenzae type b infection is followed; it is the disadvantages of pure polysaccharide vaccines that have stimulated the development of the present generation of polysaccharide-protein conjugated vaccines. From extensive clinical trials it is apparent that these are very effective in preventing disease in children. Conjugated haemophilus vaccines were introduced into the routine immunization schedules in the UK in Autumn 1992. Meningococcal A and C polysaccharide vaccines, effective for epidemic disease, are only now being developed in a protein conjugated form with the prospect of protecting young children and producing durable immunity Group B outer membrane-based meningococcal vaccines produce only a low degree of protection and much further work is needed before even the optimum vaccine constituents of this organism can be identified. Vaccines to replace multivalent pneumococcal polysaccharide mixtures are only in the very earliest stages of development.
- Publication
Journal of Antimicrobial Chemotherapy (JAC), 1993, Vol 31, Issue suppl_B, p93
- ISSN
0305-7453
- Publication type
Article